Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFR.L Regulatory News (AFR)

  • There is currently no data for AFR

Exercise of Founders' Warrants Replacement

11 Nov 2009 07:00

RNS Number : 3127C
Afren PLC
11 November 2009
 



The following amendment has been made to the ' Exercise of Founders' Warrants' announcement released on Tuesday 10th November at 5.59pm under RNS No 3100.

A correction has been made to the second table under the column heading 'Number of Shares'. The second grid now correctly states Egbert Imomoh's shareholding as 3,672,246 shares.

All other details remain unchanged.

The full amended text is shown below.

Afren plc (AFR LN)

Exercise of Founders' Warrants

Afren announced earlier today the exercise, by certain shareholders including some of the Directors (the "Founder Shareholders"), of 40,000,000 warrants over Ordinary Shares (the "Founder Shares") issued pursuant to the Company's Founders' Investment and Warrant Scheme at an exercise price of 37.95 pence per warrant, raising approximately £15 million (US$25 million) (before expenses) for the Company. 

In order to finance the exercise of these warrants and to pay tax obligations arising from the exercise, the Founder Shareholders agreed to sell certain of the Founder Shares in the Placing at the Placing Price. Following determination of the Placing Price earlier today, the Founder Shareholders have agreed to sell 24,513,100 Founder Shares at the Placing Price of 81 pence per share. The following Directors have exercised the following number of warrants and agreed to sell the following number of Founders Shares:

Director

Number of warrants

Founder Shares sold

Egbert Imomoh

6,000,000

3,100,212

Osman Shahenshah

12,000,000

9,230,486

Shahid Ullah

4,000,000

2,756,039

Constantine Ogunbiyi

4,000,000

2,909,324

Completion of the issue and sale of the Founder Shares is expected to occur at the same time as the Placing closes.

Following the exercise of the warrants and sale of the 24,513,100 Founder Shares, the following Directors will have holdings in the Company's shares (the percentage of issued share capital being based upon the expected issued share capital of the Company immediately following the issue of the New Shares in the Placing and the Founder Shares)

Director

Number of shares

Percentage of share capital

Egbert Imomoh

3,672,246

0.41%

Osman Shahenshah

4,181,515

0.47%

Shahid Ullah

3,081,461

0.35%

Constantine Ogunbiyi

1,295,676

0.15%

Capitalised terms used, but not defined in this announcement have the same meanings as set out in the announcement released by the Company earlier today in relation to the Placing

Pelham Public Relations

+44 20 7337 1500

James Henderson

Mark Antelme

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURVKRKURAAAA
Date   Source Headline
31st Jul 201510:39 amRNSCorporate update
27th Jul 20157:00 amRNSUpdate on General Meeting
21st Jul 20154:31 pmRNSUpdate on Upcoming General Meeting
15th Jul 20157:33 amRNSOperational and financial update
15th Jul 20157:30 amRNSSuspension - Afren PLC
8th Jul 20157:00 amRNSPublication of Supplementary Prospectus
1st Jul 20154:54 pmRNSDirector Declaration
25th Jun 20153:31 pmRNSResult of AGM
25th Jun 201511:00 amRNSAGM Statement
25th Jun 20157:00 amRNSBoard changes
22nd Jun 20157:00 amRNSLaunch of shareholder information microsite
19th Jun 20156:26 pmRNSProposed Debt Restructuring and Refinancing
12th Jun 20154:06 pmRNSExecutive Director Resignation / COO Appointment
10th Jun 20157:00 amRNSInterest payment due on 2020 Notes
29th May 20157:00 amRNSInterim Management Statement
29th May 20157:00 amRNSFinal Amount of the New Senior Notes
28th May 201510:58 amRNSNotification of Major Interest in Shares
18th May 20157:00 amRNSResignation of Non-Executive Directors
11th May 20157:00 amRNSInterest payment due on 2019 Notes
30th Apr 20154:37 pmRNSAnnual Financial Report
30th Apr 20154:34 pmRNSCompletion of interim funding
30th Apr 20154:31 pmRNS2014 Full Year Results
9th Apr 20157:00 amRNSInterest payment due on 2019 Notes
8th Apr 201510:34 amRNSResponse to AMNI's allegations regarding Okoro
7th Apr 201511:40 amRNSResponse to reports regarding CEO
1st Apr 20152:08 pmRNSUpdate on interim funding
30th Mar 20154:35 pmRNSPrice Monitoring Extension
23rd Mar 20157:00 amRNSUpdate on discussions with bondholders
20th Mar 20154:40 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Mar 20154:40 pmRNSSecond Price Monitoring Extn
16th Mar 20154:35 pmRNSPrice Monitoring Extension
13th Mar 20157:00 amRNSTrading statement and operations update
4th Mar 20157:00 amRNSUpdate on the Review of Afren's Capital Structure
2nd Mar 20157:00 amRNSUpdate on the Review of Afren's Capital Structure
17th Feb 20152:27 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
17th Feb 20152:22 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
16th Feb 20155:44 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
16th Feb 201511:30 amRNSForm 8.5 (EPT/RI)
16th Feb 201511:07 amRNSForm 8.5 (EPT/RI) - Afren Plc
16th Feb 201511:06 amRNSForm 8.5 (EPT/RI) - Afren Plc
16th Feb 201511:01 amPRNForm 8.3 - Afren Plc
16th Feb 201510:46 amRNSForm 8.5 (EPT/RI)
13th Feb 20154:35 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
13th Feb 20154:22 pmRNSForm 8.5 (EPT/RI) - Replacement Afren Plc
13th Feb 20154:01 pmRNSOffer Talks Terminated
13th Feb 20152:49 pmBUSForm 8.3 - AFREN PLC
13th Feb 20152:17 pmRNSForm 8.3 - [Afren PLC]
13th Feb 20151:56 pmRNSOffer Talks Terminated
13th Feb 20151:43 pmRNSForm 8.3 - Afren PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.